scispace - formally typeset
Search or ask a question

Does donating plasma make you immunocompromised? 

Answers from top 10 papers

More filters
Papers (10)Insight
BookDOI
C. Th Smit Sibinga, P. C. Das, S. Seidl 
01 Jan 1985
12 Citations
As this plasma fractionation and blood transfusion, it will really give you the good idea to be successful.
Results are better in immunocompetent patients as compared to those who are immunocompromised.
The results indicate considerable interest in donating oocytes among a subset of women in Sweden.
Therefore, its occurrence in severely immunocompromised patients is not expected.
Our prospective findings support this, indicating that neither body weight nor the amounts of plasma donated per kilogram of body weight per session were associated with ceasing from donating for medical reasons, no matter whether related or unrelated to the plasma donations themselves.
One Sentence Summary Evaluation of SARS-CoV-2 anti-spike protein IgM, IgG, and live-virus neutralizing titer profiles reveals that the optimal window for donating convalescent plasma for use in immunotherapy is within the first 60 days of symptom onset.
Although significant numbers of hemochromatosis patients reported donating blood for therapeutic reasons, our findings suggest that this population does not present a greater risk to blood safety than other donors.
Together, these findings better define the optimal window for donating convalescent plasma useful for immunotherapy of COVID-19 patients and reveal important predictors of an ideal plasma donor, including age and COVID-19 disease severity score.
We contend that paid plasma donors make an undeniable contribution to the supply of sufficient safe plasma products globally and that this is crucial for the wellbeing of vulnerable patients (Figure 1).
For patients with myasthenia gravis, this immunoadsorbent can provide an alternative to plasma exchange that does not require the use of plasma products.